A detailed history of Atalanta Sosnoff Capital, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Atalanta Sosnoff Capital, LLC holds 763,844 shares of BSX stock, worth $69.6 Million. This represents 1.38% of its overall portfolio holdings.

Number of Shares
763,844
Previous 767,320 0.45%
Holding current value
$69.6 Million
Previous $59.1 Million 8.32%
% of portfolio
1.38%
Previous 1.33%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$72.96 - $84.0 $253,608 - $291,984
-3,476 Reduced 0.45%
763,844 $64 Million
Q2 2024

Aug 13, 2024

BUY
$67.33 - $77.71 $781,431 - $901,902
11,606 Added 1.54%
767,320 $59.1 Million
Q1 2024

May 14, 2024

BUY
$57.6 - $68.62 $1.41 Million - $1.68 Million
24,543 Added 3.36%
755,714 $51.8 Million
Q4 2023

Feb 12, 2024

SELL
$48.64 - $57.81 $556,149 - $660,999
-11,434 Reduced 1.54%
731,171 $42.3 Million
Q3 2023

Nov 13, 2023

SELL
$50.19 - $54.68 $1.06 Million - $1.15 Million
-21,108 Reduced 2.76%
742,605 $39.2 Million
Q2 2023

Aug 07, 2023

SELL
$49.72 - $54.64 $16.1 Million - $17.7 Million
-324,351 Reduced 29.81%
763,713 $41.3 Million
Q1 2023

May 11, 2023

SELL
$45.09 - $50.03 $962,761 - $1.07 Million
-21,352 Reduced 1.92%
1,088,064 $54.4 Million
Q4 2022

May 22, 2023

BUY
$39.56 - $47.22 $428,593 - $511,581
10,834 Added 1.0%
1,098,898 $50.9 Million
Q4 2022

Feb 09, 2023

SELL
$39.56 - $47.22 $520,609 - $621,415
-13,160 Reduced 1.17%
1,109,416 $51.3 Million
Q3 2022

Oct 12, 2022

SELL
$36.71 - $109.66 $159,211 - $475,595
-4,337 Reduced 0.38%
1,122,576 $43.5 Million
Q2 2022

Jul 14, 2022

SELL
$35.24 - $47.1 $978,509 - $1.31 Million
-27,767 Reduced 2.4%
1,126,913 $42 Million
Q1 2022

Apr 11, 2022

BUY
$40.9 - $45.1 $1.58 Million - $1.74 Million
38,621 Added 3.46%
1,154,680 $51.1 Million
Q4 2021

Jan 25, 2022

SELL
$38.07 - $44.87 $11.4 Million - $13.4 Million
-298,613 Reduced 21.11%
1,116,059 $47.4 Million
Q3 2021

Oct 14, 2021

BUY
$41.23 - $45.88 $35.8 Million - $39.8 Million
868,038 Added 158.8%
1,414,672 $61.4 Million
Q2 2021

Jul 13, 2021

BUY
$38.58 - $44.24 $1.14 Million - $1.3 Million
29,479 Added 5.7%
546,634 $23.4 Million
Q1 2021

Apr 20, 2021

SELL
$35.27 - $39.67 $60,135 - $67,637
-1,705 Reduced 0.33%
517,155 $20 Million
Q4 2020

Jan 14, 2021

SELL
$33.15 - $41.97 $29 Million - $36.7 Million
-873,677 Reduced 62.74%
518,860 $18.7 Million
Q3 2020

Oct 14, 2020

SELL
$34.44 - $42.23 $1.37 Million - $1.68 Million
-39,683 Reduced 2.77%
1,392,537 $53.2 Million
Q2 2020

Jul 21, 2020

SELL
$30.19 - $39.11 $14 Million - $18.1 Million
-463,369 Reduced 24.44%
1,432,220 $50.3 Million
Q1 2020

Apr 16, 2020

BUY
$25.83 - $45.71 $10.7 Million - $19 Million
415,093 Added 28.04%
1,895,589 $61.9 Million
Q4 2019

Jan 23, 2020

SELL
$37.87 - $45.37 $709,115 - $849,553
-18,725 Reduced 1.25%
1,480,496 $66.9 Million
Q3 2019

Oct 15, 2019

BUY
$40.31 - $43.45 $12.4 Million - $13.3 Million
306,933 Added 25.74%
1,499,221 $61 Million
Q2 2019

Jul 15, 2019

SELL
$34.91 - $42.98 $1.15 Million - $1.42 Million
-32,961 Reduced 2.69%
1,192,288 $51.2 Million
Q1 2019

Apr 09, 2019

BUY
$32.91 - $40.75 $306,688 - $379,749
9,319 Added 0.77%
1,225,249 $47 Million
Q4 2018

Jan 09, 2019

SELL
$31.73 - $39.04 $306,733 - $377,399
-9,667 Reduced 0.79%
1,215,930 $43 Million
Q3 2018

Oct 10, 2018

SELL
$32.83 - $38.63 $704,367 - $828,806
-21,455 Reduced 1.72%
1,225,597 $47.2 Million
Q2 2018

Jul 11, 2018

BUY
$26.84 - $34.32 $859,121 - $1.1 Million
32,009 Added 2.63%
1,247,052 $40.8 Million
Q1 2018

Apr 06, 2018

BUY
$25.2 - $28.54 $575,996 - $652,338
22,857 Added 1.92%
1,215,043 $33.2 Million
Q4 2017

Jan 09, 2018

SELL
$24.79 - $29.8 $651,778 - $783,501
-26,292 Reduced 2.16%
1,192,186 $29.6 Million
Q3 2017

Oct 10, 2017

BUY
$26.26 - $29.17 $32 Million - $35.5 Million
1,218,478
1,218,478 $35.5 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Atalanta Sosnoff Capital, LLC Portfolio

Follow Atalanta Sosnoff Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atalanta Sosnoff Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atalanta Sosnoff Capital, LLC with notifications on news.